Scientists develop "smart insulin" for type 1 diabetes, potentially reducing injections from daily to weekly.

Scientists have developed a revolutionary "smart insulin" for type 1 diabetes patients, mimicking natural blood sugar fluctuations and potentially reducing injections from 10 times daily to once a week. Funded projects aim to create glucose-responsive insulins (GRIs) that activate in response to blood sugar levels, helping manage glycemic control and avoiding hypoglycemia. This advancement could significantly improve treatment for millions of patients worldwide.

7 months ago
4 Articles